Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production

The vast majority of commercially available inactivated influenza vaccines are produced from egg-grown or cell-grown live influenza virus. The first step in the production process is virus inactivation with β-propiolactone (BPL) or formaldehyde (FA). Recommendations for production of inactivated vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Rodriguez, José, Signorazzi, Aurora, Holtrop, Marijke, de Vries-Idema, Jacqueline, Huckriede, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115651/
https://www.ncbi.nlm.nih.gov/pubmed/30765167
http://dx.doi.org/10.1016/j.vaccine.2019.01.086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115651/
https://www.ncbi.nlm.nih.gov/pubmed/30765167
http://dx.doi.org/10.1016/j.vaccine.2019.01.086

Ejemplares similares